Patheon Pushes for Bulk Manufacturing of Controlled Substances
Published Date: 2/18/2025
Notice
Summary
Patheon API Inc. wants to get official approval to make large amounts of certain controlled drugs. This affects anyone involved in drug manufacturing and regulation, as it could change who supplies these substances. Keep an eye out for updates, as this could impact drug availability and industry rules soon.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Bulk Controlled-Substance Application Filed
Patheon API Inc. has applied to be registered as a bulk manufacturer of basic classes of controlled substances. This notice is relevant to companies, contractors, and regulators involved in drug manufacturing and supply because, if the registration is approved, Patheon API could produce controlled drugs in large quantities.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in